(Alliance News) - AstraZeneca PLC on Monday said Imfinzi, in combination with chemotherapy, has been recommended for approval in the EU for the treatment of adult patients with resectable, early-stage and locally advanced gastric and gastroesophageal junction cancers. Read More
(Alliance News) - UK annual house price growth rises more than expected in January, while AstraZeneca starts trading in New York and FitzWalter Capital says it does not intend to make an offer for Auction Technology Group. Read More
(Alliance News) - AstraZeneca PLC on Friday said it has expands its weight-management pipeline by collaborating with China's CSPC Pharmaceuticals Group Ltd to develop next-generation injectable therapies for obesity and type 2 diabetes. Read More
(Alliance News) - Stock prices in London opened mixed on Friday, with the FTSE 100 little changed as investors digested geopolitical developments around UK-China relations and heavy flow of European economic data, while Asian markets closed lower. Read More
(Alliance News) - AstraZeneca unveils an up-to-USD3.5 billion obesity-drug collaboration with CSPC, and LSEG signs a strategic cooperation pact with ICBC during UK Prime Minister Keir Starmer's visit to China, while Airtel Africa posts strong nine-month growth. Read More
(Alliance News) - US President Donald Trump warned it would be "dangerous" for the UK to do business with China, as Keir Starmer moves to strengthen economic ties with Beijing on the final day of his visit. Read More
(Alliance News) - Pharmaceutical firm AstraZeneca PLC on Thursday unveiled plans to invest USD15 billion in China through to 2030, in an announcement that coincides with UK Prime Minister Keir Starmer's visit to Beijing. Read More
(Alliance News) - The FTSE 100 fell on Wednesday, and the oil price climbed, amid fresh geopolitical uncertainty, while the S&P 500 briefly topped 7,000 for the first time ahead of tech earnings and the US rate call. Read More
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More
(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More
(Alliance News) - The UK pub sector awaits a GBP100 million support package from the Treasury aimed at easing cost pressures, the Financial Times reports, while Sage posts 10% quarterly revenue growth and Dr Martens reports a dip in third-quarter revenue. Read More
(Alliance News) - HSBC Holdings Chair Brendan Nelson is among senior business figures set to travel to China with UK Prime Minister Keir Starmer next week, as the government seeks to reset relations with Beijing, Sky News reported on Thursday. Read More
(Alliance News) - Daiichi Sankyo Co Ltd and AstraZeneca PLC on Thursday said Chinese regulators have approved their jointly developed drug Enhertu to treat gastric cancer. Read More
(Alliance News) - The FTSE 100 shrugged off a weak start to close slightly higher on Wednesday after US President Donald Trump said he would not use force to take control of Greenland, but insisted the US must still have "ownership" of it. Read More
(Alliance News) - The UK and China will seek to re-establish a business dialogue of top executives during UK Prime Minister Keir Starmer's widely-expected visit to Beijing, Reuters reported Wednesday. Read More
(Alliance News) - Stock prices in London were lower at midday on Tuesday, as the ongoing tension between the US and Europe over Greenland rattled investor sentiment. Read More
AstraZeneca PLC - Cambridge, England-based pharmaceuticals maker - Expects its shares to start trading directly on the New York Stock Exchange from Monday, February 2. This will follow Astra's American depositary shares being delisted from Nasdaq on the Friday before, January 30. Astra says the direct US listing, which it first announced in September, will "deliver a global listing for global investors in a global company". Astra's shares will remain tradable on the London Stock Exchange and Nasdaq Stockholm, and it will retain its FTSE 100 index membership. Its ticker symbol will remain 'AZN'. Read More
(Alliance News) - Daiichi Sanyko Co Ltd on Monday said EU regulators had validated an application for its breast cancer treatment, Enhertu with pertuzumab, jointly developed with AstraZeneca PLC. Read More
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More
(Alliance News) - Stock prices in London closed higher on Thursday, after a surprise drop in US jobless claims. Read More